1. P638 Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: a GETAID multicentre cohort study. (30th January 2023) Authors: Fumery, M; Defrance, A; Roblin, X; Altwegg, R; Caron, B; Hebuterne, X; Carmen, S; Meyer, A; Nachury, M; Laharie, D; Nancey, S; Le Berre, C; Serrero, M; Geyl, S; Gilletta, C; Ah Soune, P; Duveau, N; Uzza, M; Abitbol, V; Biron, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗